For research use only. Not for therapeutic Use.
MB710 (Cat.No:I031620) is a chemical compound that has gained attention for its potential therapeutic applications. It is currently being studied for its anti-inflammatory and immunomodulatory properties. Preliminary research suggests that MB710 may have beneficial effects in various inflammatory conditions and autoimmune disorders. Further studies are underway to explore its potential clinical uses.
| Catalog Number | I031620 |
| CAS Number | 2230044-57-0 |
| Synonyms | MB-710; MB 710; MB710 |
| Molecular Formula | C16H16IN3O3S |
| Purity | 98% |
| Target | MDM-2/p53 |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 2-(Diethylamino)-5-hydroxy-6-iodo-7-(1H-pyrrol-1-yl)benzo[d]thiazole-4-carboxylic acid |
| InChI | InChI=1S/C16H16IN3O3S/c1-3-19(4-2)16-18-11-9(15(22)23)13(21)10(17)12(14(11)24-16)20-7-5-6-8-20/h5-8,21H,3-4H2,1-2H3,(H,22,23) |
| InChIKey | SEBJATZOIHUGAU-UHFFFAOYSA-N |
| SMILES | O=C(C1=C2N=C(N(CC)CC)SC2=C(N3C=CC=C3)C(I)=C1O)O |
| Reference | 1: Baud MGJ, Bauer MR, Verduci L, Dingler FA, Patel KJ, Horil Roy D, Joerger AC, Fersht AR. Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. Eur J Med Chem. 2018 May 25;152:101-114. doi: 10.1016/j.ejmech.2018.04.035. Epub 2018 Apr 21. PubMed PMID: 29702446; PubMed Central PMCID: PMC5986712. |
